Bulletin
Investor Alert

Takeda Pharmaceutical Co. Ltd.

TKS: JP:4502

GO
/marketstate/country/jp

Market closed

/zigman2/quotes/201302442/delayed

¥

3,989.00

Change

+39.00 +0.99%

Volume

Volume 4.48m

Sep 18, 2020, 3:00 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/201302442/delayed

Previous close

¥ 3,950.00

¥ 3,989.00

Change

+39.00 +0.99%

Day low

Day high

¥3,950

¥3,996

Open
Open: 3,957.00

52 week low

52 week high

¥2,895

¥4,562

Open

Market cap

¥6235.21B

Average volume

3.77M

P/E ratio

59.07

Rev. per Employee

¥65.40M

EPS

67.53

Dividend

90.00

Div yield

4.51%

Ex dividend date

9/29/20

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/jp/4502

MarketWatch News on 4502

  1. Blackstone to acquire Takeda's consumer health care business for $2.3 bln: WSJ

    7:42 a.m. Aug. 24, 2020

    - Ciara Linnane

  2. Asian markets pull back ahead of Trump-Xi meeting at G-20

    1:03 a.m. June 25, 2019

    - Marketwatch

  3. Asian markets mostly rise, following Wall Street’s lead

    11:45 p.m. May 14, 2019

    - Marketwatch

  4. Asian markets rise as Trump, Kim set to meet

    9:54 a.m. Feb. 27, 2019

    - Associated Press

  5. Asian markets rise despite slower economic growth in China

    8:43 a.m. Jan. 21, 2019

    - Associated Press

  6. UPDATE: Molecular Templates' stock soars 33% premarket after development pact with Takeda Pharmaceuticals

    8:05 a.m. Sept. 19, 2018

    - Tomi Kilgore

  7. Loading more headlines...
/news/nonmarketwatch/company/jp/4502

Other News on 4502

  1. Orexigen Terminates Required Study for Diet Drug Contrave

    12:57 p.m. May 12, 2015

    - The Wall Street Journal Interactive Edition

  2. Takeda Pharmaceutical to Pay $2.4 Billion to Settle Lawsuits

    9:52 a.m. April 29, 2015

    - The Wall Street Journal Interactive Edition

  3. Merck’s Revenue Doesn’t Fit Its Stock

    8:07 p.m. April 28, 2015

    - The Wall Street Journal Interactive Edition

  4. Amgen Sees Positive Results From Kyprolis Study

    1:28 a.m. March 2, 2015

    - The Wall Street Journal Interactive Edition

  5. Valeant to Buy Salix for About $10 Billion

    9:44 p.m. Feb. 23, 2015

    - The Wall Street Journal Interactive Edition

  6. Parents Struggle to Cure Loved Ones, and Make Money

    3:27 p.m. Dec. 27, 2014

    - The Wall Street Journal Interactive Edition

  7. A Japan ETF That Capitalizes on Abenomics

    3:32 a.m. Jan. 5, 2015

    - The Wall Street Journal Interactive Edition

  8. Abilify Maker Otsuka to Buy Avanir

    3:37 a.m. Dec. 31, 2014

    - The Wall Street Journal Interactive Edition

  9. Corporate Watch: News Digest

    9:30 p.m. Oct. 27, 2014

    - The Wall Street Journal Interactive Edition

  10. Judge Cuts Damages Takeda, Lilly to Pay in Actos Case

    10:44 p.m. Oct. 27, 2014

    - The Wall Street Journal Interactive Edition

  11. FDA Approves Weight-Loss Drug

    12:51 p.m. Sept. 11, 2014

    - The Wall Street Journal Interactive Edition

  12. How Doctor Got Rich Invoking Antifraud Law

    11:39 a.m. July 24, 2014

    - The Wall Street Journal Interactive Edition

  13. Corrections & Amplifications

    2:34 a.m. Aug. 13, 2014

    - The Wall Street Journal Interactive Edition

  14. Alzheimer's Disease Fight Focuses on Preventive Treatment

    2:32 a.m. Aug. 12, 2014

    - The Wall Street Journal Interactive Edition

  15. Japan Prosecutors Charge Novartis Unit Over Research

    9:11 p.m. July 1, 2014

    - The Wall Street Journal Interactive Edition

  16. Takeda CEO Defends New President

    5:51 p.m. June 27, 2014

    - The Wall Street Journal Interactive Edition

  17. Takeda Hits Resistance in Choosing President

    9:41 a.m. June 27, 2014

    - The Wall Street Journal Interactive Edition

  18. Former Novartis Employee Arrested

    9:42 a.m. June 11, 2014

    - The Wall Street Journal Interactive Edition

  19. Takeda Won't Join M&A Frenzy, CFO Says

    7:28 a.m. May 16, 2014

    - The Wall Street Journal Interactive Edition

  20. Loading more headlines...

Rates »

Link to MarketWatch's Slice.